Waiting
for just the right time to write a new post didn’t pan out as a productive
strategy, so the time is now, right or not. My husband Sam and I spent most of
May on a once-in-a-lifetime trip, combining a thirteen-day transatlantic cruise
with another ten days split between London and Paris. Needless to say, it was
fantastic. I had been taking Afinitor since the previous December. That’s a
targeted therapy for my renal cancer. I’d switched to that after the previous
drug, Sutent, produced serious side effects—the most significant being necrosis
of the jaw where I’d previously had radiation therapy for an unrelated cancer
more than twenty years ago.
I
had purposely delayed a follow-up CT scan until after the trip, remembering
that when I began this cancer journey a year earlier, we’d had to cancel a
planned tour of Italy. So in June I had the new CT scan, and the results were
mixed. Some tumors had shrunk, some had grown. That was an indication to my
oncologist that Afinitor had run its course as an effective treatment. What
next?
Progress
is continuous in the field of cancer treatment. A year ago—even
less—immunotherapy was still making its way through the approval pipeline. Now,
fortuitously, it was ready to be used to treat kidney cancer. On August 23 I
had my first infusion of the immunotherapy drug Opdivo. Additional infusions
would follow every other week. The first infusion was administered on a Tuesday
morning. By evening I was running a fever of 101.7 F and aching all over. My
fever was slightly lower by bedtime, and the next morning I was feeling
relatively normal. Subsequent infusions to date have produced no discernible
reaction, thankfully. (That relative stability emboldened me to take my godson
on a weeklong trip a couple of states away to visit relatives.)
Unfortunately
as this new therapy was getting underway, pain in the area where my left kidney
had been removed—now the region of the central tumor, from which the metastases
have spread—had begun to increase. Trying to control the pain progressed
through several painkillers: Norco, Percocet, and now a combination of a
Fentanyl patch and Percocet (7.5-325). The Percocet is for when the patch isn’t
enough and is prescribed for every four hours. Most days I need the Percocet
around the clock.
This
past Friday I woke up experiencing shortness of breath and a sharp, stabbing
pain in the left side of my chest. Off to the Emergency Room. After a panoply
of tests, the conclusion was that I was developing pneumonia in my left lung.
(This was the same day Hillary Clinton was diagnosed with pneumonia. I don’t
have anything like her stamina.) I was prescribed an antibiotic and went home.
However, as I read about the antibiotic I became concerned about the potential
side effects. So on Saturday morning I called my family practice doctor and
obtained prescriptions for two antibiotics that I'd previously used without a
problem.
On
Sunday I was again (still) in distress with shortness of breath, so we went
back to the ER. This time, along with other tests, a CT scan was done to rule
out a pulmonary embolism (blood clot in the lung). More antibiotics were
administered by infusion and, absent any other evidence, the diagnosis of
developing pneumonia was held.
On
Monday I followed up with a visit to my oncologist, who voiced skepticism about
the “developing pneumonia” diagnosis and set in motion a consultation with a
pulmonary specialist. That is still in process.
On
Tuesday I followed up with my family practice doctor, who ordered lab work to
rule out congestive heart failure but speculated that the real cause for
shortness of breath may be the increased growth of the cancer, particularly
metastases in the left lung. Results for the congestive heart failure were
negative.
My
oncologist has suggested that, although some increase in some tumors has
occurred, it is too early in the Opdivo treatment to conclude that it is not
working. But that still leaves the shortness of breath to be addressed. So...next?
